Breast Cancer Clinical Trial
Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy
Summary
In this study we are looking at a type of radiation called proton radiation which is known to spare surrounding tissue and organs from radiation. The proton radiation will be delivered using 3D conformal proton radiation or scanned beam/IMPT (Intensity Modulated Proton Radiation Treatment). Proton radiation delivers no dose beyond the region requiring treatment. This may reduce side effects that patients would normally experience with conventional radiation therapy or other means of delivering proton radiation therapy. In this study we are evaluating the effectiveness of using proton radiation delivered to reduce side effects association with radiation treatment.
Full Description
Proton radiation will be delivered daily for approximately 5 1/2 weeks. Patients will be assessed weekly for any side effects they may be experiencing.
Patients will have follow-up visits 4 weeks after proton therapy ends, at 6 months, 12 months, and then every year for up to five years after treatment. Follow-up visits will include a physical examination, radiological imaging (if necessary), echocardiogram, and laboratory tests.
Eligibility Criteria
Inclusion Criteria:
Histologically confirmed invasive breast cancer confined to the breast and regional lymphatics
Completed mastectomy (complete not partial )breast surgery +/- reconstructive surgery
Life expectancy > 12 months
Exclusion Criteria:
Pregnant or breast-feeding
Prior therapeutic radiation > 200 cGy
History of a different malignancy unless disease-free for at least 5 years or diagnosed and treated cervical cancer in situ, or basal or squamous cell cancer of the skin
Prior investigation chemotherapy
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Boston Massachusetts, 02114, United States
How clear is this clinincal trial information?